126 related articles for article (PubMed ID: 9204379)
1. Cholinesterase inhibition by derivatives of 2-amino-4,6-dimethylpyridine.
Debord J; N'Diaye P; Bollinger JC; Fikri K; Penicaut B; Robert JM; Robert-Piessard S; Le Baut G
J Enzyme Inhib; 1997 Apr; 12(1):13-26. PubMed ID: 9204379
[TBL] [Abstract][Full Text] [Related]
2. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.
Samadi A; Marco-Contelles J; Soriano E; Alvarez-Pérez M; Chioua M; Romero A; González-Lafuente L; Gandía L; Roda JM; López MG; Villarroya M; García AG; Ríos Cde L
Bioorg Med Chem; 2010 Aug; 18(16):5861-72. PubMed ID: 20656495
[TBL] [Abstract][Full Text] [Related]
3. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
4. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors.
de Aquino RA; Modolo LV; Alves RB; de Fátima Â
Org Biomol Chem; 2013 Dec; 11(48):8395-409. PubMed ID: 24186541
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
[TBL] [Abstract][Full Text] [Related]
7. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
[TBL] [Abstract][Full Text] [Related]
8. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
11. Tacrine-sugar mimetic conjugates as enhanced cholinesterase inhibitors.
Oliveira de Santana QL; Santos Evangelista TC; Imhof P; Ferreira SB; Fernández-Bolaños JG; Sydnes MO; Lopéz Ó; Lindbäck E
Org Biomol Chem; 2021 Mar; 19(10):2322-2337. PubMed ID: 33645607
[TBL] [Abstract][Full Text] [Related]
12. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
15. Cage amines as the stopper inhibitors of cholinesterases.
Lin G; Tsai HJ; Tsai YH
Bioorg Med Chem Lett; 2003 Sep; 13(17):2887-90. PubMed ID: 14611850
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
[TBL] [Abstract][Full Text] [Related]
17. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
20. Ethyl nitrobenzoate: A novel scaffold for cholinesterase inhibition.
Yeong KY; Liew WL; Murugaiyah V; Ang CW; Osman H; Tan SC
Bioorg Chem; 2017 Feb; 70():27-33. PubMed ID: 27863748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
